Non-Hodgkin's lymphoma of the thyroid: Is more than biopsy necessary?

Christopher M. Pyke, Clive S. Grant, Thomas M. Habermann, Paul J. Kurtin, Jon A. van Heerden, Erik J. Bergstralh, Allen Kunselman, Ian D. Hay

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Whereas excisional surgery and radiotherapy have resulted in a favorable outcome when non-Hodgkin's lymphoma of the thyroid (NHLT) is confined to the thyroid gland, controversy persists over the potential advantage of aggressive debulking in favor of diagnostic biopsy alone when disease cannot be completely resected. Our aims in this study were to delineate the present role of surgery in NHLT in pre-operative staging, the impact of the extent of resection on achieving complete remission and cause-specific survival, and patterns of failure. All 62 patients who underwent primary surgery for NHLT at the Mayo Clinic between 1965 and 1989 were analyzed. By postoperative staging, 50 patients were stage IE or IIE. Overall survival was 53% and 46% at 5 and 10 years; 80% for stage IE confined to the thyroid, 58% for stage IE-extrathyroid, 50% for stage IIE, and 36% for stages IIIE and IVE. Complete remission was achieved in 88% of patients who underwent diagnostic biopsy plus adjuvant therapy alone compared to 85% for patients in whom debulking plus adjuvant therapy was used. There was no difference in cause-specific survival in these two groups or in cause-specific survival in two subgroups who achieved complete remission. Relapse after complete remission occurred in 12 (26%) of 46 patients, only 2 of whom survived long-term after salvage therapy. The role of surgery in NHLT is diminishing and advances that will increase complete remission and relapse-free survival will not likely involve more aggressive surgical resections.

Original languageEnglish (US)
Pages (from-to)604-609
Number of pages6
JournalWorld Journal of Surgery
Volume16
Issue number4
DOIs
StatePublished - Jul 1 1992

Fingerprint

Non-Hodgkin's Lymphoma
Thyroid Gland
Biopsy
Survival
Recurrence
Salvage Therapy
Personal Autonomy
Radiotherapy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Pyke, C. M., Grant, C. S., Habermann, T. M., Kurtin, P. J., van Heerden, J. A., Bergstralh, E. J., ... Hay, I. D. (1992). Non-Hodgkin's lymphoma of the thyroid: Is more than biopsy necessary? World Journal of Surgery, 16(4), 604-609. https://doi.org/10.1007/BF02067333
Pyke, Christopher M. ; Grant, Clive S. ; Habermann, Thomas M. ; Kurtin, Paul J. ; van Heerden, Jon A. ; Bergstralh, Erik J. ; Kunselman, Allen ; Hay, Ian D. / Non-Hodgkin's lymphoma of the thyroid : Is more than biopsy necessary?. In: World Journal of Surgery. 1992 ; Vol. 16, No. 4. pp. 604-609.
@article{2d9978239824443081e99921888b2f6c,
title = "Non-Hodgkin's lymphoma of the thyroid: Is more than biopsy necessary?",
abstract = "Whereas excisional surgery and radiotherapy have resulted in a favorable outcome when non-Hodgkin's lymphoma of the thyroid (NHLT) is confined to the thyroid gland, controversy persists over the potential advantage of aggressive debulking in favor of diagnostic biopsy alone when disease cannot be completely resected. Our aims in this study were to delineate the present role of surgery in NHLT in pre-operative staging, the impact of the extent of resection on achieving complete remission and cause-specific survival, and patterns of failure. All 62 patients who underwent primary surgery for NHLT at the Mayo Clinic between 1965 and 1989 were analyzed. By postoperative staging, 50 patients were stage IE or IIE. Overall survival was 53{\%} and 46{\%} at 5 and 10 years; 80{\%} for stage IE confined to the thyroid, 58{\%} for stage IE-extrathyroid, 50{\%} for stage IIE, and 36{\%} for stages IIIE and IVE. Complete remission was achieved in 88{\%} of patients who underwent diagnostic biopsy plus adjuvant therapy alone compared to 85{\%} for patients in whom debulking plus adjuvant therapy was used. There was no difference in cause-specific survival in these two groups or in cause-specific survival in two subgroups who achieved complete remission. Relapse after complete remission occurred in 12 (26{\%}) of 46 patients, only 2 of whom survived long-term after salvage therapy. The role of surgery in NHLT is diminishing and advances that will increase complete remission and relapse-free survival will not likely involve more aggressive surgical resections.",
author = "Pyke, {Christopher M.} and Grant, {Clive S.} and Habermann, {Thomas M.} and Kurtin, {Paul J.} and {van Heerden}, {Jon A.} and Bergstralh, {Erik J.} and Allen Kunselman and Hay, {Ian D.}",
year = "1992",
month = "7",
day = "1",
doi = "10.1007/BF02067333",
language = "English (US)",
volume = "16",
pages = "604--609",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer New York",
number = "4",

}

Pyke, CM, Grant, CS, Habermann, TM, Kurtin, PJ, van Heerden, JA, Bergstralh, EJ, Kunselman, A & Hay, ID 1992, 'Non-Hodgkin's lymphoma of the thyroid: Is more than biopsy necessary?', World Journal of Surgery, vol. 16, no. 4, pp. 604-609. https://doi.org/10.1007/BF02067333

Non-Hodgkin's lymphoma of the thyroid : Is more than biopsy necessary? / Pyke, Christopher M.; Grant, Clive S.; Habermann, Thomas M.; Kurtin, Paul J.; van Heerden, Jon A.; Bergstralh, Erik J.; Kunselman, Allen; Hay, Ian D.

In: World Journal of Surgery, Vol. 16, No. 4, 01.07.1992, p. 604-609.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Non-Hodgkin's lymphoma of the thyroid

T2 - Is more than biopsy necessary?

AU - Pyke, Christopher M.

AU - Grant, Clive S.

AU - Habermann, Thomas M.

AU - Kurtin, Paul J.

AU - van Heerden, Jon A.

AU - Bergstralh, Erik J.

AU - Kunselman, Allen

AU - Hay, Ian D.

PY - 1992/7/1

Y1 - 1992/7/1

N2 - Whereas excisional surgery and radiotherapy have resulted in a favorable outcome when non-Hodgkin's lymphoma of the thyroid (NHLT) is confined to the thyroid gland, controversy persists over the potential advantage of aggressive debulking in favor of diagnostic biopsy alone when disease cannot be completely resected. Our aims in this study were to delineate the present role of surgery in NHLT in pre-operative staging, the impact of the extent of resection on achieving complete remission and cause-specific survival, and patterns of failure. All 62 patients who underwent primary surgery for NHLT at the Mayo Clinic between 1965 and 1989 were analyzed. By postoperative staging, 50 patients were stage IE or IIE. Overall survival was 53% and 46% at 5 and 10 years; 80% for stage IE confined to the thyroid, 58% for stage IE-extrathyroid, 50% for stage IIE, and 36% for stages IIIE and IVE. Complete remission was achieved in 88% of patients who underwent diagnostic biopsy plus adjuvant therapy alone compared to 85% for patients in whom debulking plus adjuvant therapy was used. There was no difference in cause-specific survival in these two groups or in cause-specific survival in two subgroups who achieved complete remission. Relapse after complete remission occurred in 12 (26%) of 46 patients, only 2 of whom survived long-term after salvage therapy. The role of surgery in NHLT is diminishing and advances that will increase complete remission and relapse-free survival will not likely involve more aggressive surgical resections.

AB - Whereas excisional surgery and radiotherapy have resulted in a favorable outcome when non-Hodgkin's lymphoma of the thyroid (NHLT) is confined to the thyroid gland, controversy persists over the potential advantage of aggressive debulking in favor of diagnostic biopsy alone when disease cannot be completely resected. Our aims in this study were to delineate the present role of surgery in NHLT in pre-operative staging, the impact of the extent of resection on achieving complete remission and cause-specific survival, and patterns of failure. All 62 patients who underwent primary surgery for NHLT at the Mayo Clinic between 1965 and 1989 were analyzed. By postoperative staging, 50 patients were stage IE or IIE. Overall survival was 53% and 46% at 5 and 10 years; 80% for stage IE confined to the thyroid, 58% for stage IE-extrathyroid, 50% for stage IIE, and 36% for stages IIIE and IVE. Complete remission was achieved in 88% of patients who underwent diagnostic biopsy plus adjuvant therapy alone compared to 85% for patients in whom debulking plus adjuvant therapy was used. There was no difference in cause-specific survival in these two groups or in cause-specific survival in two subgroups who achieved complete remission. Relapse after complete remission occurred in 12 (26%) of 46 patients, only 2 of whom survived long-term after salvage therapy. The role of surgery in NHLT is diminishing and advances that will increase complete remission and relapse-free survival will not likely involve more aggressive surgical resections.

UR - http://www.scopus.com/inward/record.url?scp=0026664958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026664958&partnerID=8YFLogxK

U2 - 10.1007/BF02067333

DO - 10.1007/BF02067333

M3 - Article

C2 - 1413831

AN - SCOPUS:0026664958

VL - 16

SP - 604

EP - 609

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 4

ER -

Pyke CM, Grant CS, Habermann TM, Kurtin PJ, van Heerden JA, Bergstralh EJ et al. Non-Hodgkin's lymphoma of the thyroid: Is more than biopsy necessary? World Journal of Surgery. 1992 Jul 1;16(4):604-609. https://doi.org/10.1007/BF02067333